These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8123487)

  • 1. Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma.
    Evans TR; Rowlands MG; Law M; Coombes RC
    Br J Cancer; 1994 Mar; 69(3):555-61. PubMed ID: 8123487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location.
    Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ
    Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of retinoic acid and palm oil carotenoids on oestrone sulphatase and oestradiol-17beta hydroxysteroid dehydrogenase activities in MCF-7 and MDA-MB-231 breast cancer cell lines.
    Ng JH; Nesaretnam K; Reimann K; Lai LC
    Int J Cancer; 2000 Oct; 88(1):135-8. PubMed ID: 10962451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control and expression of oestrone sulphatase activities in human breast cancer.
    Pasqualini JR; Chetrite G; Nestour EL
    J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer.
    Evans TR; Rowlands MG; Silva MC; Law M; Coombes RC
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):583-7. PubMed ID: 8476770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin-like growth factors I and II on oestrone sulphatase activity in human breast cancer cell lines.
    Hwa IA; Reimann K; Lim PK; Lai LC
    Int J Mol Med; 1999 Aug; 4(2):175-8. PubMed ID: 10402485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women.
    Elsadig RE; Reimann K; Yip CH; Lai LC
    Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors.
    Purohit A; Chapman O; Duncan L; Reed MJ
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):563-6. PubMed ID: 1562528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrone sulphatase activity in mammary tumours and the liver of N-nitrosomethylurea treated rats.
    Evans TR; Chander SK; Rowlands MG; Coombes RC
    Br J Cancer; 1992 Jan; 65(1):72-6. PubMed ID: 1733443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of breast cyst fluid on oestrone sulphatase activity in MCF-7 breast cancer cells.
    Erbas H; Lennard TW; Lai LC
    Anticancer Res; 1996; 16(2):833-6. PubMed ID: 8687137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells.
    Chetrite G; Varin C; Delalonde L; Pasqualini JR
    Anticancer Res; 1993; 13(4):931-4. PubMed ID: 8352561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.
    Winstanley J; Cooke T; George WD; Murray G; Holt S; Croton R; Griffiths K; Nicholson R
    Br J Cancer; 1991 Jul; 64(1):99-101. PubMed ID: 1854633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours.
    Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
    Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Bari M; Leon AE; Vinante O; Bruscagnin G
    Br J Cancer; 1993 Aug; 68(2):374-9. PubMed ID: 8347494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrone sulphatase activity of the rat uterus in different hormonal states.
    Utaaker E; Støa KF
    Horm Res; 1980; 13(3):180-5. PubMed ID: 7203400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues.
    Yamamoto Y; Yamashita J; Toi M; Muta M; Nagai S; Hanai N; Furuya A; Osawa Y; Saji S; Ogawa M
    Oncol Rep; 2003; 10(4):791-6. PubMed ID: 12792725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate.
    Purohit A; Froome VA; Wang DY; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 1997 May; 62(1):45-51. PubMed ID: 9366497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of tissue oestradiol levels in human breast cancer.
    Santen RJ
    Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of subchronic administration of oestrone-3-O-sulphamate on oestrone sulphatase activity in liver, spleen and white blood cells of ovariectomized rats.
    Barth A; Römer W; Oettel M
    Arch Toxicol; 2000 Sep; 74(7):366-71. PubMed ID: 11043491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrone sulphate, adipose tissue, and breast cancer.
    Hawkins RA; Thomson ML; Killen E
    Breast Cancer Res Treat; 1985; 6(1):75-87. PubMed ID: 4052635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.